COX1 / Cyclooxygenase 1 overexpression 293T lysate (whole cell) (ab94213)
Overview
-
Product name
COX1 / Cyclooxygenase 1 overexpression 293T lysate (whole cell)
See all COX1 / Cyclooxygenase 1 lysates -
General notes
ab94213 is a 293T cell transfected lysate in which Human COX1 / Cyclooxygenase 1 has been transiently over-expressed using a pCMV-COX1 / Cyclooxygenase 1 plasmid. The lysate is provided in 1X Sample Buffer.
-
Tested applications
Suitable for: WBmore details
Properties
-
Mycoplasma free
Yes -
Form
Liquid -
Storage instructions
Shipped on dry ice. Upon delivery aliquot and store at -20ºC. Avoid freeze / thaw cycles. -
Storage buffer
Constituents: 0.01% Bromophenol blue, 2.3% Beta mercaptoethanol, 2% Sodium lauryl sulfate, 0.788% Tris HCl, 10% Glycerol (glycerin, glycerine) -
Concentration information loading...
-
Research areas
-
Background
Function: May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells. Pathway: Lipid metabolism; prostaglandin biosynthesis. Similarity: Belongs to the prostaglandin G/H synthase family. Contains 1 EGF-like domain.
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab94213 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
WB |
Use at an assay dependent dilution.
|
Notes |
---|
WB
Use at an assay dependent dilution. |
Images
-
ab94213 at 15μg/lane on an SDS-PAGE gel
-
All lanes : Anti-COX1 / Cyclooxygenase 1 antibody (ab89630) at 1/500 dilution
Lane 1 :COX1 / Cyclooxygenase 1 overexpression 293T lysate (whole cell) (ab94213)
Lane 2 : 293T non-transfected lysate
Lysates/proteins at 25 µg per lane.
Secondary
All lanes : Goat Anti-mouse IgG (H and L) HRP conjugated at 1/2500 dilution
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab94213 has not yet been referenced specifically in any publications.